Komori
Sato Sho-Ji (8065) · InitiativeAdvanced

Expansion of the lifestyle business through in-house products, online sales and outlet stores

First written in FY2016. 21 of 38 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-09-07.

38entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2020-Q3 – FY2022-Q1WorsenedFY2022-Q2 – FY2024-Q3AdvancedFY2025-H1 – 2026-09-072016: 320162017: 420172018: 420182019: 420192020: 420202021: 420212022: 320222023: 420232024: 220242025: 220252026: 42026
Same theme, other companies
Expansion of the lifestyle business through proprietary products and multiple channelsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. 2026-09-07AdvancedOther Disclosures

    「Through this exhibition, we will communicate the outstanding design of these products and the appeal of Japanese manufacturing to customers overseas.」

    Kitchenware designed by Sori Yanagi was exhibited at an international trade fair in France, creating a specific opportunity to promote and sell the Company’s products overseas.
  2. FY2026AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥11,498 million, up 18.0% year on year, and operating income was ¥634 million, up 47.4%, owing mainly to steady sales of the Company’s products.」

    Sales of the Company’s products remained steady, resulting in higher net sales and operating income in the Life Sales Business.
  3. FY2026-H1AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥5,423 million, up 27.1% year on year, and operating income was ¥293 million, up 186.1%, owing mainly to steady sales of the Company’s products.」

    Sales of the Company’s products remained steady, resulting in substantial increases in net sales and operating income in the Life Sales Business.
  4. FY2025AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥9,744 million, up 19.7% year on year, and operating income was ¥430 million, up 77.9%, owing mainly to steady overseas sales of products proposed by the Company.」

    Steady overseas sales of products proposed by the Company resulted in substantial increases in net sales and operating income for the full fiscal year.
  5. FY2025-H1AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥4,265 million, up 18.3% year on year, and operating income was ¥102 million, up 365.6%, owing mainly to steady overseas sales of products proposed by the Company.」

    In addition to its conventional sales of the Company’s products, steady overseas sales of products proposed by the Company resulted in substantial increases in net sales and operating income in the Life Sales Business.
  6. FY2024-Q3WorsenedAnnual report

    「In the Life Sales Business, the Company continued to promote sales of its products from the previous fiscal year, but net sales were ¥5,644 million, down 14.5% year on year, and operating income was ¥100 million, down 61.1%, owing mainly to higher procurement costs for imported products and other factors.」

    Although sales of the Company’s products continued, higher procurement costs for imported products and other factors resulted in lower net sales and operating income, with operating income down 61.1% year on year.
  7. FY2024-Q2WorsenedAnnual report

    「In the Life Sales Business, the Company continued to promote sales of its products from the previous fiscal year, but net sales were ¥3,606 million, down 20.5% year on year, and operating income was ¥22 million, down 88.2%, owing mainly to higher procurement costs for imported products and other factors.」

    Although sales of the Company’s products continued, higher procurement costs for imported products and other factors resulted in substantial declines in net sales and operating income.
  8. FY2024-Q1WorsenedAnnual report

    「In the Life Sales Business, the Company continued to promote sales of its products from the previous fiscal year, but net sales were ¥1,758 million, down 13.8% year on year, and operating income was ¥9 million, down 90.6%, owing mainly to higher procurement costs for imported products and other factors.」

    Although sales of the Company’s products continued, higher procurement costs for imported products and other factors resulted in lower net sales, while operating income fell 90.6% year on year.
  9. FY2023WorsenedAnnual report

    「In the Life Sales Business, the Company continued to promote sales of its products from the previous fiscal year as demand for at-home consumption increased amid calls to refrain from going out, but net sales were ¥8,610 million, down 19.5% year on year, and operating income was ¥302 million, down 64.5%, owing mainly to higher procurement costs for imported products and other factors.」

    Although sales of the Company’s products continued, net sales and operating income both declined owing to higher procurement costs for imported products and other factors, and the deterioration in operating income continued.
  10. FY2023-Q3WorsenedAnnual report

    「In the Life Sales Business, the Company continued to promote sales of its products from the previous fiscal year as demand for at-home consumption increased amid calls to refrain from going out, but net sales were ¥6,602 million, down 18.3% year on year, and operating income was ¥259 million, down 64.6%, owing mainly to higher procurement costs for imported products and other factors.」

    Although sales of the Company’s products continued, higher procurement costs for imported products and other factors resulted in lower net sales and operating income, with operating income down 64.6% year on year.
  11. FY2023-Q2WorsenedAnnual report

    「In the Life Sales Business, the Company continued to promote sales of its products from the previous fiscal year as demand for at-home consumption increased amid calls to refrain from going out, but net sales were ¥4,537 million, down 13.7% year on year, and operating income was ¥187 million, down 60.8%, owing mainly to higher procurement costs for imported products and other factors.」

    Although sales of the Company’s products continued, higher procurement costs for imported products and other factors resulted in lower net sales and operating income, with operating income down 60.8% year on year.
  12. FY2023-Q1WorsenedAnnual report

    「In the Life Sales Business, the Company continued to promote sales of its products from the previous fiscal year as demand for at-home consumption increased amid calls to refrain from going out, but net sales were ¥2,039 million, down 27.7% year on year, and operating income was ¥106 million, down 64.9%, owing mainly to higher procurement costs for imported products and other factors.」

    Although sales of the Company’s products continued, net sales and operating income declined owing to higher procurement costs for imported products and other factors, with operating income down 64.9% year on year.
  13. FY2022-Q3WorsenedAnnual report

    「In the Life Sales Business, the Company promoted sales of its products as demand for at-home consumption increased amid calls to refrain from going out, but net sales were ¥8,082 million, with no year-on-year comparison available, and operating income was ¥733 million, down 13.7%.」

    Although the Company promoted sales of its products, operating income in the Life Sales Business fell 13.7% year on year, indicating a deterioration in profitability.
  14. FY2022-Q2WorsenedAnnual report

    「In the Life Sales Business, the Company promoted sales of its products as demand for at-home consumption increased amid calls to refrain from going out, but net sales were ¥5,259 million, with no year-on-year comparison available, and operating income was ¥476 million, down 7.6%.」

    Although the Company promoted sales of its products amid stronger demand for at-home consumption, operating income fell 7.6% year on year, indicating a deterioration in profitability.
  15. FY2022-Q1AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥2,820 million, with no year-on-year comparison available, while operating income was ¥302 million, up 15.7% year on year, owing mainly to the active promotion of sales of the Company’s products as demand for at-home consumption increased amid calls to refrain from going out.」

    Against a backdrop of demand for at-home consumption, the Company promoted sales of its products, and operating income rose 15.7% year on year.
  16. FY2021AdvancedAnnual report

    「In the Life Sales Business, as demand for at-home consumption increased amid calls to refrain from going out and sales of the Company’s products remained strong, net sales were ¥10,914 million, up 21.4% year on year, and operating income was ¥1,048 million, up 70.0%.」

    Against a backdrop of demand for at-home consumption, sales of the Company’s products were strong, resulting in higher net sales and operating income in the Life Sales Business.
  17. FY2021-Q3AdvancedAnnual report

    「In the Life Sales Business, as demand for at-home consumption increased amid calls to refrain from going out and sales of the Company’s products remained strong, net sales were ¥8,508 million, up 25.4% year on year, and operating income was ¥850 million, up 83.3%.」

    Against a backdrop of stronger demand for at-home consumption, sales of the Company’s products were strong, resulting in higher net sales and operating income in the Life Sales Business for the cumulative third quarter.
  18. FY2021-Q2AdvancedAnnual report

    「In the Life Sales Business, as demand for at-home consumption increased amid calls to refrain from going out and sales of the Company’s products remained strong, net sales were ¥5,612 million, up 28.5% year on year, and operating income was ¥516 million, up 100.8%.」

    Against a backdrop of stronger demand for at-home consumption, sales of the Company’s products were strong, resulting in higher net sales and operating income in the Life Sales Business. Operating income rose 100.8% year on year, and the improvement from the previous fiscal year continued.
  19. FY2021-Q1AdvancedAnnual report

    「In the Life Sales Business, as demand for at-home consumption increased amid calls to refrain from going out and sales of the Company’s products remained strong, net sales were ¥2,904 million, up 37.3% year on year, and operating income was ¥261 million, up 187.3%.」

    Against a backdrop of stronger demand for at-home consumption amid calls to refrain from going out, sales of the Company’s products were strong, resulting in higher net sales and operating income in the Life Sales Business. Operating income rose 187.3% year on year, indicating concrete progress in the existing sales initiatives for the Company’s products.
  20. FY2020AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥8,992 million, up 5.7% year on year, and operating income was ¥616 million, up 18.5%, owing mainly to steady sales of the Company’s products.」

    Sales of the Company’s products remained steady, resulting in higher net sales and operating income in the Life Sales Business.
  21. FY2020-Q3AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥6,785 million, up 4.0% year on year, and operating income was ¥463 million, up 4.8%, owing mainly to steady sales of the Company’s products.」

    Sales of the Company’s products remained steady, and both net sales and operating income exceeded the previous-year period.
  22. FY2020-Q2WorsenedAnnual report

    「In the Life Sales Business, net sales rose 3.4% year on year to ¥4,366 million, owing mainly to steady sales to existing customers, but operating income fell 18.3% to ¥257 million, owing mainly to a decline in sales of the Company’s products.」

    Although sales to existing customers increased net sales, operating income fell 18.3% year on year owing mainly to the decline in sales of the Company’s products.
  23. FY2020-Q1WorsenedAnnual report

    「In the Life Sales Business, the Company promoted sales of its products, but owing mainly to sluggish domestic sales, net sales were ¥2,114 million, down 8.2% year on year, and operating income was ¥91 million, down 52.7%.」

    Although the Company promoted sales of its products, net sales declined due to sluggish domestic sales, and operating income fell 52.7% year on year.
  24. FY2019WorsenedAnnual report

    「In the Life Sales Business, the Company promoted sales of its products, but net sales were ¥8,505 million, up 0.9% year on year, while operating income was ¥523 million, down 6.6%.」

    Although the Company promoted sales of its products, net sales edged up only slightly and operating income fell 6.6% year on year.
  25. FY2019-Q3WorsenedAnnual report

    「In the Life Sales Business, the Company promoted sales of its products, but net sales were ¥6,522 million, up 1.4% year on year, while operating income was ¥444 million, down 6.6%.」

    Although net sales edged up as the Company promoted sales of its products, operating income fell 6.6% year on year, indicating a deterioration in profitability from the profit growth through the previous quarter.
  26. FY2019-Q2AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥4,223 million, up 3.1% year on year, and operating income was ¥316 million, up 8.7%, owing mainly to progress in expanding sales channels for the Company’s products.」

    The Company advanced the expansion of sales channels for its products, and both net sales and operating income exceeded the previous-year period.
  27. FY2019-Q1AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥2,302 million, up 14.3% year on year, and operating income was ¥193 million, up 3.0%, owing mainly to progress in expanding sales channels for the Company’s products.」

    The Company advanced the expansion of sales channels for its products, and both net sales and operating income exceeded the previous-year period. Performance improved from the previous fiscal year’s declines in sales and profit.
  28. FY2018WorsenedAnnual report

    「In the Life Sales Business, the Company promoted sales of its products, but net sales were ¥8,430 million, down 2.1% year on year, and operating income was ¥560 million, down 12.3%.」

    Although the Company promoted sales of its products, both net sales and operating income fell below the previous-year period, confirming a deterioration in performance on a full-year basis.
  29. FY2018-Q3WorsenedAnnual report

    「In the Life Sales Business, the Company promoted sales of its products, but net sales were ¥6,431 million, down 2.6% year on year, and operating income was ¥475 million, down 7.4%.」

    Despite promoting sales of the Company’s products, both net sales and operating income fell below the previous-year period, indicating a deterioration in performance from the cumulative second quarter of the previous fiscal year.
  30. FY2018-Q2AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥4,094 million, down 1.7% year on year, while operating income was ¥290 million, up 12.4%, owing mainly to the active promotion of sales of the Company’s products.」

    Although net sales declined, operating income rose 12.4% year on year due to the promotion of sales of the Company’s products, indicating an improvement from the slight increase in profit in the previous quarter.
  31. FY2018-Q1RestatedAnnual report

    「In the Life Sales Business, net sales were ¥2,014 million, down 10.3% year on year, while operating income was ¥187 million, up 0.3%, owing mainly to the active promotion of sales of the Company’s products.」

    Although the active sale of the Company’s products continues, net sales declined and the increase in operating income was limited to 0.3% year on year, so this is treated as continuation rather than substantive progress.
  32. FY2017AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥8,608 million, down 1.9% year on year, while operating income was ¥638 million, up 3.8%, owing mainly to the active promotion of sales of the Company’s products.」

    The active sale of the Company’s products continued. Although net sales declined, operating income increased 3.8% year on year.
  33. FY2017-Q3AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥6,604 million, up 1.2% year on year, while operating income was ¥513 million, up 19.3%, owing mainly to the active promotion of sales of the Company’s products.」

    The active sale of the Company’s products continued, with measurable progress reflected in increases in net sales and operating income.
  34. FY2017-Q2AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥4,167 million, up 9.5% year on year, due mainly to the expansion of sales channels for the Company’s products, while operating income was ¥258 million, up 46.2%.」

    The expansion of sales channels for the Company’s products continued, with measurable progress reflected in increases in net sales and operating income.
  35. FY2017-Q1AdvancedAnnual report

    「In the Life Sales Business, net sales were ¥2,244 million, up 16.2% year on year, due mainly to the expansion of sales channels for the Company’s products, while operating income was ¥187 million, up 128.6%, reflecting the effect of improved profitability and other factors.」

    The expansion of sales channels for the Company’s products progressed measurably, as reflected in increases in net sales and operating income.
  36. FY2016First statedAnnual report

    「In the Lifestyle Sales Business, in addition to conventional household goods, business-use products, and precious metal and jewelry products, the company develops original-brand products and low-priced products manufactured overseas, promoting domestic sales centered on its proprietary products. It is also strengthening sales through mail-order and television shopping, developing personal karaoke sales and the associated song-streaming business, and expanding sales channels by opening more directly operated outlet stores. At the same time, it is pursuing market development and new customer acquisition in North America.」

    Product development, mail-order and television shopping, karaoke, expansion of the outlet store network, and development of the North American market are being pursued as an integrated set of initiatives.
Moved together

"Expansion of Overseas Sales Offices for Electronic Materials" moved the same way as this thread, in the same document, in 16 of its 38 moves.

16121211109★123456
  1. ★This thread
  2. 1Expansion of Overseas Sales Offices for Electronic Materials16×
  3. 2Sustained Earnings Growth12×
  4. 3Import and sales of non-ferrous metals, expanding into Southeast Asia12×
  5. 4Market Price Fluctuations for Products and Raw Materials11×
  6. 5Capital investment in the sales network, production and processing facilities, and labor-saving equipment10×
  7. 6Active Expansion into Overseas Markets9×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Sato Sho-Ji's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Other Disclosures of 2026-09-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion of the lifestyle business through in-house products, online sales and outlet stores | SATO SHO-JI CORPORATION (8065) | Komori